Bone sarcomas: ESMO-PaedCan-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Primary bone tumours are rare, accounting for < 0.2% of malignant neoplasms registered in the EUROCARE (European Cancer Registry based study on survival and care of cancer patients) database [1]. Different bone tumour subtypes have distinct patterns of incidence, and each has no more than 0.3 incident cases per 100 000 per year. Osteosarcoma (OS) and Ewing sarcoma (ES) have a relatively high incidence in the second decade of life, whereas chondrosarcoma (CS) is more common in older age [2–4].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These strata were based on studies showing that a shorter relapse-free interval and older age are prognostic for shorter OS in patients with osteosarcoma.”
From Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma (2024) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., Kotz, R., Salzer-Kuntschik, M., Werner, M., Winkelmann, W., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.776 · Cited by 2,393
Self-citationGrier, H. E., Krailo, M. D., Tarbell, N. J., Link, M. P., Fryer, C. J. H., Pritchard, D. J., Gebhardt, M. C., Dickman, P. S., Perlman, E. J., Meyers, P. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020890 · Cited by 1,328
Cotterill, S. J., Ahrens, S., Paulussen, M., Jürgens, H. F., Voûte, P. A., Gadner, H., & Craft, A. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.17.3108 · Cited by 1,040
Kager, L., Zoubek, A., Pötschger, U., Kastner, U., Flege, S., Kempf-Bielack, B., Branscheid, D., Kotz, R., Salzer-Kuntschik, M., Winkelmann, W., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.132 · Cited by 934
Self-citationGrünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854
Womer, R. B., West, D. C., Krailo, M. D., Dickman, P. S., Pawel, B. R., Grier, H. E., Marcus, K., Sailer, S., Healey, J. H., Dormans, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5703 · Cited by 757
The Clinical Approach Towards Chondrosarcoma
Gelderblom, H., Hogendoorn, P. C. W., Dijkstra, S. D., van Rijswijk, C. S., Krol, A. D., Taminiau, A. H. M., & Bovée, J. V. M. G. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0237 · Cited by 756
Self-citationMeyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., Goorin, A. M., Harris, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.14.0095 · Cited by 752 · cited 2×
“Muramyl tripeptide added to postoperative ChT was associated with a significant advantage in overall survival and a non-significant trend in event-free survival in one large randomised trial [II, C] [41].”
BackgroundSorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration
Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Le Deley, M.-C., Kovar, H., Grimer, R., Whelan, J., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 722
Self-citationDescriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 683
Self-citationThe hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.
Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264080-00002 · Cited by 648
Kempf-Bielack, B., Bielack, S. S., Jürgens, H., Branscheid, D., Berdel, W. E., Exner, G. U., Göbel, U., Helmke, K., Jundt, G., Kabisch, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.063 · Cited by 643 · cited 3×
“Complete removal of all metastases must be attempted [III, B], as the disease is otherwise almost universally fatal; more than a third of patients with a complete second surgical remission survive for > 5 years [51].”
BackgroundSelf-citationDykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
Vujovic, S., Henderson, S., Presneau, N., Odell, E., Jacques, T., Tirabosco, R., Boshoff, C., & Flanagan, A. (2006) · The Journal of Pathology · doi:10.1002/path.1969 · Cited by 589
Chawla, S., Henshaw, R., Seeger, L., Choy, E., Blay, J.-Y., Ferrari, S., Kroep, J., Grimer, R., Reichardt, P., Rutkowski, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70277-8 · Cited by 587
Self-citationNesbit, M. E., Gehan, E. A., Burgert, E. O., Vietti, T. J., Cangir, A., Tefft, M., Evans, R., Thomas, P., Askin, F. B., & Kissane, J. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.10.1664 · Cited by 570
Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C., van den Berg, H., Brennan, B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30214-5 · Cited by 551
Self-citationStacchiotti, S., & Sommer, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71190-8 · Cited by 501
Self-citationOsteosarcoma, Chondrosarcoma, and Chordoma
Whelan, J. S., & Davis, L. E. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.1743 · Cited by 479
Self-citationDescriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
Self-citationFerrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., Capanna, R., Bernini, G., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5785 · Cited by 435
Self-citationBielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0734 · Cited by 422
Self-citationAntonescu, C. R., Owosho, A. A., Zhang, L., Chen, S., Deniz, K., Huryn, J. M., Kao, Y.-C., Huang, S.-C., Singer, S., Tap, W., et al. (2017) · American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000846 · Cited by 405
Goorin, A. M., Schwartzentruber, D. J., Devidas, M., Gebhardt, M. C., Ayala, A. G., Harris, M. B., Helman, L. J., Grier, H. E., & Link, M. P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.165 · Cited by 395
Improved survival using specialized multidisciplinary board in sarcoma patients
Blay, J.-Y., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx484 · Cited by 371
Self-citationDiagnostic Imaging of Solitary Tumors of the Spine: What to Do and Say
Rodallec, M. H., Feydy, A., Larousserie, F., Anract, P., Campagna, R., Babinet, A., Zins, M., & Drapé, J.-L. (2008) · RadioGraphics · doi:10.1148/rg.284075156 · Cited by 360
Schuck, A., Ahrens, S., Paulussen, M., Kuhlen, M., Könemann, S., Rübe, C., Winkelmann, W., Kotz, R., Dunst, J., Willich, N., et al. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03797-5 · Cited by 348
Lewis, I. J., Nooij, M. A., Whelan, J., Sydes, M. R., Grimer, R., Hogendoorn, P. C. W., Memon, M. A., Weeden, S., Uscinska, B. M., van Glabbeke, M., et al. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk015 · Cited by 346
Self-citationGrignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
Self-citationWhelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu526 · Cited by 333
Self-citationBacci, G., Ferrari, S., Bertoni, F., Rimondini, S., Longhi, A., Bacchini, P., Forni, C., Manfrini, M., Donati, D., & Picci, P. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.4 · Cited by 327
Self-citationPostrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
Ferrari, S., Briccoli, A., Mercuri, M., Bertoni, F., Picci, P., Tienghi, A., Del Prever, A. B., Fagioli, F., Comandone, A., & Bacci, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.141 · Cited by 316 · cited 3×
“In fact, there are subsets of patients who can have a very similar prognosis to that of localised disease, provided surgical removal of all known metastatic deposits is achievable [III, B] [49].”
BackgroundSelf-citationRisk of recurrence and survival after relapse in patients with Ewing sarcoma
Stahl, M., Ranft, A., Paulussen, M., Bölling, T., Vieth, V., Bielack, S., Görtitz, I., Braun‐Munzinger, G., Hardes, J., Jürgens, H., et al. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23040 · Cited by 315
Self-citationPicci, P., Sangiorgi, L., Rougraff, B. T., Neff, J. R., Casadei, R., & Campanacci, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2699 · Cited by 300
Self-citationEffectiveness of Carbon Ion Radiotherapy in the Treatment of Skull-Base Chordomas
Schulz-Ertner, D., Karger, C. P., Feuerhake, A., Nikoghosyan, A., Combs, S. E., Jäkel, O., Edler, L., Scholz, M., & Debus, J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.059 · Cited by 290
Phase II Study of Imatinib in Advanced Chordoma
Stacchiotti, S., Longhi, A., Ferraresi, V., Grignani, G., Comandone, A., Stupp, R., Bertuzzi, A., Tamborini, E., Pilotti, S., Messina, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.3656 · Cited by 276
Self-citationPaulussen, M., Craft, A. W., Lewis, I., Hackshaw, A., Douglas, C., Dunst, J., Schuck, A., Winkelmann, W., Köhler, G., Poremba, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5720 · Cited by 263
Self-citationEefting, D., Schrage, Y. M., Geirnaerdt, M. J. A., Le Cessie, S., Taminiau, A. H. M., Bovée, J. V. M. G., & Hogendoorn, P. C. W. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817eec2b · Cited by 261
Advanced chondrosarcomas: role of chemotherapy and survival
Italiano, A., Mir, O., Cioffi, A., Palmerini, E., Piperno-Neumann, S., Perrin, C., Chaigneau, L., Penel, N., Duffaud, F., Kurtz, J. E., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt374 · Cited by 258
Self-citationUK guidelines for the management of bone sarcomas
On behalf of the British Sarcoma Group, Gerrand, C., Athanasou, N., Brennan, B., Grimer, R., Judson, I., Morland, B., Peake, D., Seddon, B., & Whelan, J. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0047-1 · Cited by 258
Self-citationIncidence and survival of malignant bone sarcomas in England 1979–2007
Whelan, J., McTiernan, A., Cooper, N., Wong, Y. K., Francis, M., Vernon, S., & Strauss, S. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.26426 · Cited by 255
Self-citationFuchs, B., & Pritchard, D. J. (2002) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200204000-00007 · Cited by 248
DeLaney, T. F., Liebsch, N. J., Pedlow, F. X., Adams, J., Weyman, E. A., Yeap, B. Y., Depauw, N., Nielsen, G. P., Harmon, D. C., Yoon, S. S., et al. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23617 · Cited by 246
Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx054 · Cited by 241
Self-citationDedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group
Grimer, R. J., Gosheger, G., Taminiau, A., Biau, D., Matejovsky, Z., Kollender, Y., San-Julian, M., Gherlinzoni, F., & Ferrari, C. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.016 · Cited by 235
Cartilaginous Tumors: Fast Contrast-enhanced MR Imaging
Geirnaerdt, M. J. A., Hogendoorn, P. C. W., Bloem, J. L., Taminiau, A. H. M., & van der Woude, H.-J. (2000) · Radiology · doi:10.1148/radiology.214.2.r00fe12539 · Cited by 230
Piperno-Neumann, S., Le Deley, M.-C., Rédini, F., Pacquement, H., Marec-Bérard, P., Petit, P., Brisse, H., Lervat, C., Gentet, J.-C., Entz-Werlé, N., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30096-1 · Cited by 219
Self-citationCurrent strategies of chemotherapy in osteosarcoma
Carrle, D., & Bielack, S. S. (2006) · International Orthopaedics · doi:10.1007/s00264-006-0192-x · Cited by 217
Self-citationCangir, A., Vietti, T. J., Gehan, E. A., Burgert, E. O., Thomas, P., Tefft, M., Nesbit, M. E., Kissane, J., & Pritchard, D. (1990) · Cancer · doi:10.1002/1097-0142(19900901)66:5<887::aid-cncr2820660513>3.0.co;2-r · Cited by 217
Translocation involving chromosome 22 in Ewing's Sarcoma. A cytogenetic study of four fresh tumors
Aurias, A., Rimbaut, C., Buffe, D., Zucker, J.-M., & Mazabraud, A. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90003-7 · Cited by 215
Bovée, J. V., Cleton-Jansen, A.-M., Taminiau, A. H., & Hogendoorn, P. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70282-5 · Cited by 211
Le Deley, M.-C., Delattre, O., Schaefer, K.-L., Burchill, S. A., Koehler, G., Hogendoorn, P. C. W., Lion, T., Poremba, C., Marandet, J., Ballet, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3585 · Cited by 199
Dedifferentiated Chondrosarcoma: The Role of Chemotherapy with Updated Outcomes
Dickey, I. D., Rose, P. S., Fuchs, B., Wold, L. E., Okuno, S. H., Sim, F. H., & Scully, S. P. (2004) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200411000-00008 · Cited by 194
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite
Grünewald, T. G. P., Bernard, V., Gilardi-Hebenstreit, P., Raynal, V., Surdez, D., Aynaud, M.-M., Mirabeau, O., Cidre-Aranaz, F., Tirode, F., Zaidi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3363 · Cited by 186
Meyer, J. S., Nadel, H. R., Marina, N., Womer, R. B., Brown, K. L. B., Eary, J. F., Gorlick, R., Grier, H. E., Randall, R. L., Lawlor, E. R., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21596 · Cited by 180 · cited 1×
“When the diagnosis of malignancy cannot be excluded with certainty on radiographs, the next step should be magnetic resonance imaging (MRI) of the whole compartment with adjacent joints, which is regarded today as the best modality for local staging of extremity and pelvic tumours [13].”
Backgroundvan der Woude, H. J., Bloem, J. L., Verstraete, K. L., Taminiau, A. H., Nooy, M. A., & Hogendoorn, P. C. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.3.7645476 · Cited by 178
Prognostic factors in localized extremity osteosarcoma: A systematic review
Bramer, J. A. M., van Linge, J. H., Grimer, R. J., & Scholten, R. J. P. M. (2009) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2009.01.011 · Cited by 177
Frezza, A. M., Cesari, M., Baumhoer, D., Biau, D., Bielack, S., Campanacci, D. A., Casanova, J., Esler, C., Ferrari, S., Funovics, P. T., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.11.007 · Cited by 176
Self-citationGiant cell tumour of bone in the denosumab era
van der Heijden, L., Dijkstra, P. D. S., Blay, J.-Y., & Gelderblom, H. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.021 · Cited by 172
Self-citationTopotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
Hunold, A., Weddeling, N., Paulussen, M., Ranft, A., Liebscher, C., & Jürgens, H. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20719 · Cited by 168
Haeusler, J., Ranft, A., Boelling, T., Gosheger, G., Braun‐Munzinger, G., Vieth, V., Burdach, S., van den Berg, H., Juergens, H., & Dirksen, U. (2010) · Cancer · doi:10.1002/cncr.24740 · Cited by 166
Bone cancer incidence by morphological subtype: a global assessment
Valery, P. C., Laversanne, M., & Bray, F. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0607-3 · Cited by 164
Bacci, G., Forni, C., Longhi, A., Ferrari, S., Donati, D., De Paolis, M., Barbieri, E., Pignotti, E., Rosito, P., & Versari, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.022 · Cited by 164
Self-citationOncologic PET/MRI, Part 2: Bone Tumors, Soft-Tissue Tumors, Melanoma, and Lymphoma
Buchbender, C., Heusner, T. A., Lauenstein, T. C., Bockisch, A., & Antoch, G. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109306 · Cited by 163
Andreou, D., Bielack, S. S., Carrle, D., Kevric, M., Kotz, R., Winkelmann, W., Jundt, G., Werner, M., Fehlberg, S., Kager, L., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq589 · Cited by 158
Self-citationvan Doorninck, J. A., Ji, L., Schaub, B., Shimada, H., Wing, M. R., Krailo, M. D., Lessnick, S. L., Marina, N., Triche, T. J., Sposto, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.5845 · Cited by 152
Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults
Dantonello, T. M., Int‐Veen, C., Leuschner, I., Schuck, A., Furtwängler, R., Claviez, A., Schneider, D. T., Klingebiel, T., Bielack, S., & Kościelniak, E. (2008) · Cancer · doi:10.1002/cncr.23457 · Cited by 149
Self-citationKuwazuru, Y., Yoshimura, A., Hanada, S., Utsunomiya, A., Makino, T., Ishibashi, K., Kodama, M., Iwahashi, M., Arima, T., & Akiyama, S. (1990) · Cancer · doi:10.1002/1097-0142(19900901)66:5<953::aid-cncr2820660524>3.0.co;2-z · Cited by 148
van der Woude, H.-J., Bloem, J. L., & Hogendoorn, P. C. W. (1998) · Skeletal Radiology · doi:10.1007/s002560050339 · Cited by 142
Bernstein, M. L., Devidas, M., Lafreniere, D., Souid, A.-K., Meyers, P. A., Gebhardt, M., Stine, K., Nicholas, R., Perlman, E. J., Dubowy, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1717 · Cited by 136
High-Dose Chemotherapy in the Treatment of Relapsed Osteosarcoma: An Italian Sarcoma Group Study
Fagioli, F., Aglietta, M., Tienghi, A., Ferrari, S., Brach del Prever, A., Vassallo, E., Palmero, A., Biasin, E., Bacci, G., Picci, P., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.081 · Cited by 133
Self-citationProton Therapy in Children: A Systematic Review of Clinical Effectiveness in 15 Pediatric Cancers
Leroy, R., Benahmed, N., Hulstaert, F., Damme, N. V., & Ruysscher, D. D. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.10.025 · Cited by 128
Henson, K. E., Reulen, R. C., Winter, D. L., Bright, C. J., Fidler-Benaoudia, M. M., Frobisher, C., Guha, J., Wong, K. F., Kelly, J. S., Edgar, A. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022514 · Cited by 127
Self-citationFerrari, S., Hall, K. S., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegård, T. A., del Prever, A. B., Tamburini, A., Alberghini, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq573 · Cited by 126
Self-citationFerrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., Donati, D., Kevric, M., Brosjö, O., Comandone, A., et al. (2018) · Tumori Journal · doi:10.5301/tj.5000696 · Cited by 123 · cited 1×
“Some studies have put a threshold of 25 years of age to remove HD-MTX from the induction regimen [45], while others included HD-MTX for older patients [46].”
BackgroundSelf-citationBompas, E., Cesne, A. L., Tresch‐Bruneel, E., Lebellec, L., Laurence, V., Collard, O., Saâda-Bouzid, E., Isambert, N., Blay, J., Amela, E. Y., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv300 · Cited by 122
Self-citationRadiotherapeutic Factors in the Management of Cervical-basal Chordomas and Chondrosarcomas
Noël, G., Feuvret, L., Ferrand, R., Boisserie, G., Mazeron, J.-J., & Habrand, J.-L. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143330.30405.aa · Cited by 121
Fox, E., Patel, S., Wathen, J. K., Schuetze, S., Chawla, S., Harmon, D., Reinke, D., Chugh, R., Benjamin, R. S., & Helman, L. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2010-0265 · Cited by 121
Rutkowski, P. L., Gaston, C. L., Borkowska, A. M., Stacchiotti, S., Gelderblom, H. A. J., Baldi, G. G., Palmerini, E., Casali, P. G., Gronchi, A., Parry, M., et al. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.03.020 · Cited by 118
Self-citationPeriosteal osteosarcoma – a European review of outcome
Grimer, R. J., Bielack, S., Flege, S., Cannon, S. R., Foleras, G., Andreeff, I., Sokolov, T., Taminiau, A., Dominkus, M., San-Julian, M., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.052 · Cited by 110
Self-citationDo pathological fractures influence survival and local recurrence rate in bony sarcomas?
Bramer, J. A. M., Abudu, A. A., Grimer, R. J., Carter, S. R., & Tillman, R. M. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.07.004 · Cited by 109
Staging of Primary Malignancies of Bone
Heck, R. K., Peabody, T. D., & Simon, M. A. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.366 · Cited by 104
Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R. H., Fink, F. M., Kościelniak, E., Delattre, O., Strehl, S., Ambros, P. F., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.419 · Cited by 103
Yamada, Y., Kuda, M., Kohashi, K., Yamamoto, H., Takemoto, J., Ishii, T., Iura, K., Maekawa, A., Bekki, H., Ito, T., et al. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2072-8 · Cited by 102
Picci, P., Vanel, D., Briccoli, A., Talle, K., Haakenaasen, U., Malaguti, C., Monti, C., Ferrari, C., Bacci, G., Sæter, G., et al. (2001) · Annals of Oncology · doi:10.1023/a:1013103511633 · Cited by 100
Self-citationPalmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., Fagioli, F., Asaftei, S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2312-3 · Cited by 98
Earlier diagnosis of bone and soft-tissue tumours
Grimer, R. J., & Briggs, T. W. R. (2010) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.92b11.24326 · Cited by 97
Bramwell, V. H. C., Steward, W. P., Nooij, M., Whelan, J., Craft, A. W., Grimer, R. J., Taminau, A. H. M., Cannon, S. R., Malcolm, A. J., Hogendoorn, P. C. W., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3260 · Cited by 93
Self-citationDynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma
Coninck, T. D., Jans, L. B. O., Sys, G. M. L., Huysse, W. C. J., Verstraeten, T. R. G. M., Forsyth, R. G., Poffyn, B., & Verstraete, K. L. (2013) · European Radiology · doi:10.1007/s00330-013-2913-z · Cited by 90
Whole Lung Irradiation in Patients with Exclusively Pulmonary Metastases of Ewing Tumors
Bölling, T., Schuck, A., Paulussen, M., et al. (2008) · Strahlentherapie und Onkologie · doi:10.1007/s00066-008-1810-x · Cited by 88
Newman, E. N., Jones, R. L., & Hawkins, D. S. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24406 · Cited by 88
Self-citationEwing sarcoma: prognostic criteria, outcomes and future treatment
Leavey, P. J., & Collier, A. B. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.4.617 · Cited by 82
Incidence of Biopsy-Proven Bone Tumors in Children
van den Berg, H., Kroon, H. M. J. A., Slaar, A., et al. (2008) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e3181558cb5 · Cited by 81
Machado, I., Noguera, R., Pellin, A., Lopez-Guerrero, J. A., Piqueras, M., Navarro, S., & Llombart-Bosch, A. (2009) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181a06f66 · Cited by 79
Periosteal osteosarcoma: A single‐institution experience
Cesari, M., Alberghini, M., Vanel, D., Palmerini, E., Staals, E. L., Longhi, A., Abate, M., Ferrari, C., Balladelli, A., & Ferrari, S. (2011) · Cancer · doi:10.1002/cncr.25718 · Cited by 78
Self-citationRadiotherapy in the Management of Giant Cell Tumor of Bone
Shi, W., Indelicato, D. J., Reith, J. D., et al. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3182568fb6 · Cited by 70
Response to high‐dose ifosfamide in patients with advanced/recurrent Ewing sarcoma
Ferrari, S., del Prever, A. B., Palmerini, E., Staals, E., Berta, M., Balladelli, A., Picci, P., Fagioli, F., Bacci, G., & Vanel, D. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21917 · Cited by 68
Self-citationPopulation-based study of giant cell tumor of bone in Sweden (1983–2011)
Amelio, J., Rockberg, J., Hernandez, R. K., Sobocki, P., Stryker, S., Bach, B. A., Engellau, J., & Liede, A. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.03.014 · Cited by 65
Massimo, B., Giovanni, G., Stefano, F., Eleonora, B., Adalberto, B. D. P., Sandra, A., Francesco, S., Massimo, A., & Franca, F. (2009) · Cancer · doi:10.1002/cncr.24368 · Cited by 61
Nooij, M. A., Whelan, J. S., Bramwell, V. H. C., Taminiau, A. T., Cannon, S. R., Hogendoorn, P. C. W., Pringle, J. A. S., Uscinska, B., Weeden, S., Kirkpatrick, A., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.026 · Cited by 60
Self-citationShapeero, L. G., & Vanel, D. (2000) · Seminars in Musculoskeletal Radiology · doi:10.1055/s-2000-6861 · Cited by 60
Bone Cancer Progression and Therapeutic Approaches
Heymann, D. (2009) · Cited by 56
Lebellec, L., Chauffert, B., Blay, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.037 · Cited by 56
Self-citationRegional Variation and Challenges in Estimating the Incidence of Giant Cell Tumor of Bone
Liede, A., Bach, B. A., Stryker, S., Hernandez, R. K., Sobocki, P., Bennett, B., & Wong, S. S. (2014) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.00367 · Cited by 55
Brewster, D. H., Clark, D., Hopkins, L., Bauer, J., Wild, S. H., Edgar, A. B., & Wallace, W. H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.788 · Cited by 50
Laitinen, M., Parry, M., Albergo, J. I., Jeys, L. M., Abudu, A., Carter, S. R., Sumathi, V. P., & Grimer, R. J. (2015) · The Bone & Joint Journal · doi:10.1302/0301-620x.97b12.35749 · Cited by 50
Delaying surgery with chemotherapy for osteosarcoma of the extremities
Bielack, S., Machatschek, J.-N., Flege, S., & Jürgens, H. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.6.1243 · Cited by 48
Self-citationAdjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone
Gouin, F., Rochwerger, A., Marco, A. D., Rosset, P., Bonnevialle, P., Fiorenza, F., & Anract, P. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.003 · Cited by 45
Saumet, L., Deschamps, F., Marec‐Bérard, P., Gaspar, N., Corradini, N., Petit, P., Sirvent, N., & Brugières, L. (2014) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2014.926469 · Cited by 40
Self-citationRecommendations for the reporting of bone tumors
Abdul‐Karim, F. W., Bauer, T. W., Kilpatrick, S. E., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.004 · Cited by 33
Complexities in Interpretation of Osteosarcoma Clinical Trial Results
Hunsberger, S., Freidlin, B., & Smith, M. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.3484 · Cited by 32
Berger, M., Grignani, G., Giostra, A., Ferrari, S. M., Ferraresi, V., Tamburini, A., Cefalo, G., Carnevale‐Schianca, F., Vassallo, E., Picci, P., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr542 · Cited by 29
Self-citationInterventional radiology: Role in the treatment of sarcomas
de Baère, T., Tselikas, L., Gravel, G., Hakimé, A., Deschamps, F., Honoré, C., Mir, O., & Cesne, A. L. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.02.017 · Cited by 29
Results of Diagnostic Review in Pediatric Bone Tumors and Tumorlike Lesions
van den Berg, H., Slaar, A., Kroon, H. M. J. A., et al. (2008) · Journal of Pediatric Orthopaedics · doi:10.1097/bpo.0b013e31817bb800 · Cited by 26
Frezza, A. M., Beale, T., Bomanji, J. B., Jay, A., Kalavrezos, N., Dileo, P., Whelan, J. S., & Strauss, S. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-23 · Cited by 21
Self-citationYu, W., Liu, Z., Tang, L., Lin, F., Yao, Y., & Shen, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-14521-7 · Cited by 21
Pakos, E. E., Grimer, R. J., Peake, D., Spooner, D. A., Carter, S. R., Tillman, R. M., Abudu, S., & Jeys, L. M. (2011) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.93b9.27166 · Cited by 20
Epidemiology of Primary Bone Tumors and Economical Aspects of Bone Metastases
Hauben, E. I., & Hogendoorn, P. C. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00001-3 · Cited by 18
Whelan, J. S., Deley, M. L., Dirksen, U., Judson, I. R., Hawkins, D. S., Berg, H. V. D., Ladenstein, R. L., Kruseová, J., Ranft, A., Amler, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.11000 · Cited by 13
Self-citationThe final diagnosis in patients with a suspected primary malignancy of bone
Malhas, A., Grimer, R. J., Abudu, A., Carter, S. R., Tillman, R. M., & Jeys, L. M. (2011) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.93b7.25727 · Cited by 10
Duffaud, F., Blay, J., Mir, O., Boudou, P., Piperno-Neumann, S., Penel, N., Bompas, E., Delcambre, C., Kalbacher, E., Italiano, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.11504 · Cited by 8
Self-citation
Cited by
Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy096 · Cited by 1,614
Self-citationBeird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660
Self-citationSurgery in reference centers improves survival of sarcoma patients: a nationwide study
Blay, J.-Y., Honoré, C., Stoeckle, E., Meeus, P., Jafari, M., Gouin, F., Anract, P., Ferron, G., Rochwerger, A., Ropars, M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz124 · Cited by 338
Self-citationMolecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Self-citationLilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 283
Metadata
- Authors
- Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., Montemurro, M., Morland, B., Pantaleo, M. A., Piana, R., Picci, P., Piperno-Neumann, S., Pousa, A. L., Reichardt, P., Robinson, M. H., Rutkowski, P., Safwat, A. A., Schöffski, P., Sleijfer, S., Stacchiotti, S., Strauss, S. J., Sundby Hall, K., Unk, M., Van Coevorden, F., van der Graaf, W. T. A., Whelan, J., Wardelmann, E., Zaikova, O., & Blay, J. Y.
- Affiliations
- University of Milan (IT)
- Olgahospital (DE)
- Instituto Português de Oncologia Francisco Gentil (PT)
- Turku University Hospital (FI)
- Essen University Hospital (DE)
- Istituti Fisioterapici Ospitalieri (IT)
- Institut Curie (FR)
- Royal Manchester Children's Hospital (GB)
- Vienna General Hospital (AT)
- Hospital Universitario Virgen del Rocío (ES)
- Institut Gustave Roussy (FR)
- Centro di Riferimento Oncologico (IT)
- University College London Hospitals NHS Foundation Trust (GB)
- Ghent University Hospital (BE)
- Skåne University Hospital (SE)
- Ospedale Regina Margherita (IT)
- Russian Cancer Research Center NN Blokhin (RU)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Istituto Ortopedico Rizzoli (IT)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Leiden University Medical Center (NL)
- Institut Jules Bordet (BE)
- Candiolo Cancer Institute (IT)
- University of Mannheim (DE)
- Ludwig-Maximilians-Universität München (DE)
- Helsinki University Hospital (FI)
- Royal Marsden Hospital (GB)
- Institute of Cancer Research (GB)
- University Medical Center Groningen (NL)
- Radboud University Medical Center (NL)
- St Anna Children's Hospital (AT)
- Masaryk Memorial Cancer Institute (CZ)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
- Tel Aviv Sourasky Medical Center (IL)
- Centre Hospitalier Universitaire Vaudois (CH)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Hospital de Sant Pau (ES)
- Helios Hospital Berlin-Buch (DE)
- Weston Park Cancer Centre (GB)
- Aarhus University Hospital (DK)
- Universitair Ziekenhuis Leuven (BE)
- Erasmus MC Cancer Institute (NL)
- Institute of Oncology Ljubljana (SI)
- University Hospital Münster (DE)
- Oslo University Hospital (NO)
- Lyon 1 Université (FR)
- ORCID
- Casali, P.G.
- Bielack, S.
- Aro, H.T.
- Bauer, S.
- Biagini, R.
- Bonvalot, S.
- Brennan, B.
- Brugières, L.
- Buonadonna, A.
- Dileo, P.
- Dhooge, C.
- Fagioli, F.
- Ferraresi, V.
- Ferrari, A.
- Ferrari, S.
- Frezza, A.M.
- Gaspar, N.
- Gelderblom, H.
- Gil, T.
- Grignani, G.
- Gronchi, A.
- Haas, R.L.
- Hohenberger, P.
- Issels, R.
- Joensuu, H.
- Jones, R.L.
- Judson, I.
- Jutte, P.
- Kaal, S.
- Kager, L.
- Kasper, B.
- Krákorová, D.A.
- Ladenstein, R.
- Lugowska, I.
- Montemurro, M.
- Morland, B.
- Pantaleo, M.A.
- Piana, R.
- Picci, P.
- Piperno-Neumann, S.
- Reichardt, P.
- Rutkowski, P.
- Safwat, A.A.
- Schöffski, P.
- Sleijfer, S.
- Stacchiotti, S.
- Strauss, S.J.
- Unk, M.
- Whelan, J.
- Wardelmann, E.
- Zaikova, O.
- Blay, J.Y.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv79-iv95
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2894974756
- Cited by
- 617
- References
- 125
- Citations by year
- 2026: 46 · 2025: 48 · 2024: 84 · 2023: 82 · 2022: 107 · 2021: 133 · 2020: 80 · 2019: 32 · 2018: 3
- FWCI
- 46.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by-nc-nd)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- IRIS (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Ariad Pharmaceuticals
- Medpace
- Stryker
- Exelixis
- Eisai
- Astellas Pharma
- Swedish Orphan Biovitrum
- PharmaMar
- Ipsen
- Plexxikon
- Loxo Oncology
- Daiichi Sankyo Europe
- EIT Health
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac tumors and thrombi
- Keywords
- bone sarcoma, osteosarcoma, Ewing sarcoma, chondrosarcoma, pediatric bone tumors, diagnosis, treatment, follow-up, incidence
- MeSH terms
- Positron Emission Tomography Computed Tomography, Survivorship, Adult, Aftercare, Age Factors, Antineoplastic Combined Chemotherapy Protocols, Biopsy, Bone and Bones, Bone Neoplasms, Child, Europe, Humans, Long-Term Care, Magnetic Resonance Imaging, Medical Oncology, Neoplasm Staging, Patient Participation, Radionuclide Imaging, Osteosarcoma, Self-Help Groups, Societies, Medical, Incidence, Treatment Outcome, Radiotherapy, Adjuvant, Orthopedic Procedures, Neoadjuvant Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.